Evidence map›Paper›PMID 33782003›Full record

ArticleAntimicrobial agents and chemotherapy2021

Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Collagen in the Mesenteric Lymph Nodes of Nonhuman Primates.

Erin M B Scholz, Joseph N Mwangi, Gabriela De la Cruz, Michael Nekorchuk, Chi Ngai Chan, Kathleen Busman-Sahay, Lourdes Adamson, Paul Luciw, Yuri Fedoriw, Jacob D Estes and 2 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Erin M B ScholzEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Joseph N MwangiEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Gabriela De la CruzSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Michael NekorchukVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Chi Ngai ChanVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Kathleen Busman-SahayVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Lourdes AdamsonSchool of Medicine, University of California at Davis, Davis, California, USA.
Paul LuciwSchool of Medicine, University of California at Davis, Davis, California, USA.
Yuri FedoriwSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jacob D EstesVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Elias P RosenEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Angela D M KashubaEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA akashuba@unc.edu.
University of North Carolina at Chapel Hill · USChildren's Cancer Therapy Development Institute · USUniversity of California, Davis · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue ReservoirsR01AI111891 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KASHUBA, ANGELA D · 2014 to 2018
$4.3M
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell LevelR01AI149672 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2020 to 2024
$4.0M
Novel ISH Approaches to Quantify Replication Competent ReservoirsR01AI143411 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2019 to 2023
$3.6M
STRUCTURE PREDICTION AND ANALYSIS OF RF2A AND RF2BF32AI049672 · NIAID · DONALD DANFORTH PLANT SCIENCE CENTER · PI LIU, YI · 2001 to 2003
$127k
Gates Foundation INV-002704NIAID NIH HHS F32 AI049672NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI111891NIAID NIH HHS R01 AI143411NIAID NIH HHS R01 AI149672NIH HHS P51 OD011092NIH HHS P51 OD011107
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) persistence in tissue reservoirs is a major barrier to HIV cure. While antiretrovirals (ARVs) suppress viral replication, antiretroviral therapy (ART) interruption results in rapid rebound viremia that may originate from lymphoid tissues. To understand the relationship between anatomic distribution of ARV exposure and viral expression in lymph nodes, we performed mass spectrometry imaging (MSI) of 6 ARVs, RNAscope

Indexed as

HIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsCollagenHIVLymph NodesMacaca mulattaRNA-Directed DNA PolymeraseViral LoadVirus ReplicationCollagenRNA-Directed DNA Polymeraseantiretroviral agentsdrug distributionhuman immunodeficiency virusmass spectrometry

Identifiers

PMID33782003
PMCPMC8315948
OpenAlexW3148706959

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.